The optimal level of immunosuppression in solid organ transplantation, in particular for the
liver, is a delicate balance between the benefit of preventing rejection and the adverse side …

The increasing potency of immunosuppression (IS) agents resulted in significantly
decreased rates of steroid resistant rejection and rejection related graft loss in liver …

Chronic rejection (CR) of liver allografts causes damage to intrahepatic vessels and bile
ducts and may lead to graft failure after liver transplantation. Although its prevalence has …

Background As part of liver transplantation, immunosuppression (suppressing the host
immunity) is given to prevent graft rejections resulting from the immune response of the body …

Background Liver transplantation is an established treatment option for end‐stage liver
failure. Now that newer, more potent immunosuppressants have been developed …

The use of induction immunosuppression in liver transplantation (LT) remains controversial.
This was a retrospective cohort study of adult, first-time liver-alone recipients (N= 69 349) at …

Liver transplantation (LT) is a life-saving surgery for patients with liver failure, cirrhosis, and
early-stage hepatocellular carcinoma (HCC). The first LT was performed as early as 1963 by …

Background Liver transplantation is an established treatment option for end‐stage liver
failure. To date, no consensus has been reached on the use of immunosuppressive T‐cell …

Background Liver transplantation is considered the definitive treatment for people with liver
failure. As part of post‐liver transplantation management, immunosuppression (suppressing …

Background Lung transplantation has become a valuable and well‐accepted treatment
option for most end‐stage lung diseases. Lung transplant recipients are at risk of …